课题基金 / 基金详情

Analysis of gene expression associated cancer invasion and metastasis using in situ RT-PCR method

Analysis of gene expression associated cancer invasion and metastasis using in situ RT-PCR method
原位RT-PCR方法分析癌症侵袭和转移相关基因表达
批准号:
10671476
负责人:
KANDA Kazuya
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
1.检测尿激酶型纤溶酶原激活物(UPA)、尿激酶型纤溶酶原激活剂受体(UPAR)及纤溶酶原激活物抑制物-1、2(PAI-1、PAI-2)在膀胱癌组织中的表达,探讨其在膀胱癌发生发展中的作用。UPA、uPAR、PAI-1和PAI-2mRNA在浸润性肿瘤中的表达水平明显升高,并与组织学分级有关。我们还分析了SPARC基因在膀胱癌中的表达及其与临床病理表现的关系。浸润性肿瘤的SPARC表达水平明显高于浅表性肿瘤。这些结果表明uPA、uPAR、PAI-1、PAI-2和SPARC在膀胱癌的发生发展中起重要作用。为了明确其在尿路上皮癌中的作用,本研究采用明胶酶谱技术研究了活化形式的基质金属蛋白酶-2的表达。侵袭性肿瘤组织中活化形式的基质金属蛋白酶-2的表达水平明显升高。高水平的激活形式的基质金属蛋白酶-2与病程特定的生存期缩短密切相关。提示基质金属蛋白酶-2的活化形式在尿路上皮癌的侵袭中起重要作用。我们建立了非侵袭性和侵袭性尿路上皮癌细胞系,并将侵袭性尿路上皮癌细胞系移植到SCID小鼠的膀胱内。我们分析了侵袭性尿路上皮癌细胞系向SCID小鼠膀胱形成的膀胱癌组织中MT1-MMP1和MMP2mRNA的表达定位。MT1-MMPmRNA表达位于肿瘤晚期,间质细胞表达MMP2mRNA。此外,我们现在正在分析手术获得的组织中mRNAs的定位。
英文摘要
1. we investigated the expression of urokinase-type plasminogen activator (uPA), urokinase-type plasminogen activator receptor (uPAR), and plasminogen activator inhibitor-1, 2 (PAI-1, PAI-2) in bladder cancer to determine the role of their gene expression in invasion and progression of bladder cancer. Expression levels of uPA, uPAR, PAI-1 and PAI-2 mRNA was significantly higher in invasive tumor, and was correlated with histological grade. We also analyzed the gene expression of SPARC in bladder cancer and its relationship with clinical-histopathological manifestation. Invasive tumors expressed significantly higher level of SPARC than superficial tumors. These results showed that uPA, uPAR, PAI-1, PAI-2, and SPARC played an important role in the tumor progression of bladder cancer.2. The present study investigated the expression of the activated form of MMP-2 using zelatin zymography in order to define its role in urothelial cancer. Expression levels of activated forms of MMP-2 were significantly higher in invasive tumor tissue. High levels of activated forms of MMP-2 were strongly associated with shortened course-specific survival. These findings suggest that the activated form of MMP-2 plays a significant role in invasion of urothelial cancer.3. We established non invasive and invasive urothelial cancer cell lines, and transplanted invasive urothelial cancer cell line to the bladder of SCID mice. We analyzed the mRNA localization of MT1-MMP and MMP-2 mRNA in bladder tumor tissues formed from invasive urothelial cancer cell line to the bladder of SCID mice. MT1-MMP mRNA was observed in the advanced part of tumor, and MMP-2 mRNA was observed in interstitial cells . Furthermore we are now analysing mRNAs localization in tissues obtained from surgery.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Kanda K, Kanayama H, Kagawa S: "Clinical significance of cancer invasion-metastasis associated gene expression."Proceeding of the 26th Annual Meeting of Japanese Society of Urologic Oncology. (in press).
Kanda K、Kanayama H、Kakawa S:“癌症侵袭转移相关基因表达的临床意义。”日本泌尿肿瘤学会第 26 届年会论文集。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Li N, Tsuji M, Kanda K, Murakami Y, Kanayama H, Kagawa S: "Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma"BJU Int. 85(4). 514-518 (2000)
Li N、Tsuji M、Kanda K、Murakami Y、Kanayama H、Kakawa S:“肾细胞癌中 CD44 亚型 v10 表达及其预后价值分析”BJU Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsuji M., Kanda K., Murakami Y., Kurokawa Y., Kanayama H., Sano T., Kagawa S: "Biologic markers in prostatic intraepithelial neoplasia : immunohistochemical and cytogenetic analyses"J. Med. Invest.. 46(1-2). 35-41 (1999)
Tsuji M.、Kanda K.、Murakami Y.、Kurokawa Y.、Kanayama H.、Sano T.、Kakawa S:“前列腺上皮内瘤变的生物标志物:免疫组织化学和细胞遗传学分析”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tusji M: "Biologic marker in prostatic intraepithelial neoplasma:immuno histochemical and cytogenetic analyses"J Med Invest. 46(102). 35-41 (1999)
Tusji M:“前列腺上皮内肿瘤的生物标志物:免疫组织化学和细胞遗传学分析”J Med Invest。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 14 条
    海外基金